Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanfer

Showing results (321-330 of 374) with videos related to

Pageof 38
Sort By:
British Journal of Cancer|November 22, 2012
Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivoC Weiss, O Uziel, O Wolach, et al.
Blood|March 10, 2001
Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemiaE Olavarria, E Kanfer, R Szydlo, et al.
Bone Marrow Transplantation|April 1, 1987
Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiationE J Kanfer, C D Buckner, A Fefer, et al.
Blood|October 7, 2000
Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemiaF Dazzi, R M Szydlo, N C Cross, et al.
Presse Medicale (Paris, France : 1983)|February 22, 2000
[Prevention of venous thromboembolism in a non-surgical medical ward. Proposed indications for low molecular weight heparin]J P Fagot, A Flahault, A Kanfer, et al.
Presse Medicale (Paris, France : 1983)|October 19, 2002
[Prophylactic prescription of low-molecular-weight heparin in the non-surgical setting: impact of recommendations]J P Fagot, A Flahault, M Fodil, et al.
Transplantation|June 1, 1987
Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantationF L Dulley, E J Kanfer, F R Appelbaum, et al.
The Journal of Cell Biology|January 19, 2021
Image-based pooled whole-genome CRISPRi screening for subcellular phenotypesGil Kanfer, Shireen A Sarraf, Yaakov Maman, et al.
Hematological Oncology|July 17, 2010
LACE-conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma: treatment outcome and risk factor analysis from a single centreJiří Pavlů, Holger W Auner, Sarah Ellis, et al.
Leukemia & Lymphoma|February 8, 2013
Salvage autologous stem cell transplantation for multiple myeloma relapsing or progressing after up-front autologous transplantationHolger W Auner, Richard Szydlo, Alero Rone, et al.
Pageof 38

Showing results (321-330 of 374) with videos related to

Sort By:
Pageof 38
British Journal of Cancer|November 22, 2012
Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivoC Weiss, O Uziel, O Wolach, et al.
Blood|March 10, 2001
Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemiaE Olavarria, E Kanfer, R Szydlo, et al.
Bone Marrow Transplantation|April 1, 1987
Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiationE J Kanfer, C D Buckner, A Fefer, et al.
Blood|October 7, 2000
Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemiaF Dazzi, R M Szydlo, N C Cross, et al.
Presse Medicale (Paris, France : 1983)|February 22, 2000
[Prevention of venous thromboembolism in a non-surgical medical ward. Proposed indications for low molecular weight heparin]J P Fagot, A Flahault, A Kanfer, et al.
Presse Medicale (Paris, France : 1983)|October 19, 2002
[Prophylactic prescription of low-molecular-weight heparin in the non-surgical setting: impact of recommendations]J P Fagot, A Flahault, M Fodil, et al.
Transplantation|June 1, 1987
Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantationF L Dulley, E J Kanfer, F R Appelbaum, et al.
The Journal of Cell Biology|January 19, 2021
Image-based pooled whole-genome CRISPRi screening for subcellular phenotypesGil Kanfer, Shireen A Sarraf, Yaakov Maman, et al.
Hematological Oncology|July 17, 2010
LACE-conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma: treatment outcome and risk factor analysis from a single centreJiří Pavlů, Holger W Auner, Sarah Ellis, et al.
Leukemia & Lymphoma|February 8, 2013
Salvage autologous stem cell transplantation for multiple myeloma relapsing or progressing after up-front autologous transplantationHolger W Auner, Richard Szydlo, Alero Rone, et al.
Pageof 38